INS and Wilson disease: As shown in Figure 2D-E, leflunomide treatment markedly decreased the AUC of OGTT and ITT compared to the WD mice, which indicates that leflunomide significantly improved glucose tolerance and insulin sensitivity of leflunomide-treated mice.